Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

P Dubsky, Martin Filipits, Christian F. Singer et al.|Cancer Research|2018

Cited by 2